Novel Therapeutics for Aggressive Non-Hodgkin's Lymphoma

nork Mahadevan, Daruka, Fisher, Richard I.
Argitaratua 2011

THE BTK INHIBITOR PCI-32765 SYNERGISTICALLY INCREASES PROTEASOME INHIBITOR ACTIVITY IN DLBCL AND MCL CELLS SENSITIVE OR RESISTANT TO BORTEZOMIB

nork Dasmahapatra, Girija, Patel, Hiral, Dent, Paul, Fisher, Richard I., Friedberg, Jonathan, Grant, Steven
Argitaratua 2013

The pan-HDAC inhibitor vorinostat potentiates the activity of the proteasome inhibitor carfilzomib in human DLBCL cells in vitro and in vivo

nork Dasmahapatra, Girija, Lembersky, Dmitry, Kramer, Lora, Fisher, Richard I., Friedberg, Jonathan, Dent, Paul, Grant, Steven
Argitaratua 2010

A War on Two Fronts: Cancer Care in the Time of COVID-19

nork Kutikov, Alexander, Weinberg, David S., Edelman, Martin J., Horwitz, Eric M., Uzzo, Robert G., Fisher, Richard I.
Argitaratua izan da Ann Intern Med (2020)

Bcl-2 antagonists interact synergistically with bortezomib in DLBCL cells in association with JNK activation and induction of ER stress

nork Dasmahapatra, Girija, Lembersky, Dmitry, Rahmani, Mohamed, Kramer, Lora, Friedberg, Jonathan, Fisher, Richard I., Dent, Paul, Grant, Steven
Argitaratua 2009

Natural History of CNS Relapse in Patients With Aggressive Non-Hodgkin's Lymphoma: A 20-Year Follow-Up Analysis of SWOG 8516—The Southwest Oncology Group

nork Bernstein, Steven H., Unger, Joseph M., LeBlanc, Michael, Friedberg, Jonathan, Miller, Thomas P., Fisher, Richard I.
Argitaratua izan da J Clin Oncol (2009)

Recommendations for Initial Evaluation, Staging, and Response Assessment of Hodgkin and Non-Hodgkin Lymphoma: The Lugano Classification

nork Cheson, Bruce D., Fisher, Richard I., Barrington, Sally F., Cavalli, Franco, Schwartz, Lawrence H., Zucca, Emanuele, Lister, T. Andrew
Argitaratua izan da J Clin Oncol (2014)

CARFILZOMIB INTERACTS SYNERGISTICALY WITH HISTONE DEACETYLASE INHIBITORS IN MANTLE CELL LYMPHOMA CELLS IN VITRO AND IN VIVO

nork Dasmahapatra, Girija, Lembersky, Dmitry, Son, Minkyeong P., Attkisson, Elisa, Dent, Paul, Fisher, Richard. I., Friedberg, Jonathan W., Grant, Steven
Argitaratua 2011

Retraction: Carfilzomib Interacts Synergistically with Histone Deacetylase Inhibitors in Mantle Cell Lymphoma Cells In Vitro and In Vivo

nork Dasmahapatra, Girija, Lembersky, Dmitry, Son, Minkyeong P., Attkisson, Elisa, Dent, Paul, Fisher, Richard I., Friedberg, Jonathan W., Grant, Steven
Argitaratua izan da Mol Cancer Ther (2019)

Patterns of Growth Factor Usage and Febrile Neutropenia Among Older Patients with Diffuse Large B-Cell Non-Hodgkin Lymphoma Treated with CHOP or R-CHOP: The Intergroup Experience (...

nork Morrison, Vicki A., Weller, Edie A., Habermann, Thomas M., Li, Shuli, Fisher, Richard I., Cheson, Bruce D., Peterson, Bruce A.
Argitaratua izan da Leuk Lymphoma (2016)

A Phase 2 Study of Vorinostat for Treatment of Relapsed or Refractory Hodgkin Lymphoma: SWOG S0517

nork Kirschbaum, Mark H., Goldman, Bryan H., Zain, Jasmine M., Cook, James R., Rimsza, Lisa M., Forman, Stephen J., Fisher, Richard I.
Argitaratua 2011

Aurora A inhibitor (MLN8237) plus Vincristine plus Rituximab is synthetic lethal and a potential curative therapy in aggressive B-cell non-Hodgkin lymphoma

nork Mahadevan, Daruka, Stejskal, Amy, Cooke, Laurence S., Manziello, Ann, Morales, Carla, Persky, Daniel O., Fisher, Richard I., Miller, Thomas P., Qi, Wenqing
Argitaratua izan da Clin Cancer Res (2012)

Alisertib Added to Rituximab and Vincristine Is Synthetic Lethal and Potentially Curative in Mice with Aggressive DLBCL Co-Overexpressing MYC and BCL2

nork Mahadevan, Daruka, Morales, Carla, Cooke, Laurence S., Manziello, Ann, Mount, David W., Persky, Daniel O., Fisher, Richard I., Miller, Thomas P., Qi, Wenqing
Argitaratua 2014

A Phase II Trial of Single Agent Bevacizumab in Patients with Relapsed, Aggressive Non-Hodgkin Lymphoma: Southwest Oncology Group Study S0108

nork Stopeck, Alison T., Unger, Joseph, Rimsza, Lisa M., Bellamy, William T., Iannone, Maria, Persky, Daniel O., LeBlanc, Michael, Fisher, Richard I., Miller, Thomas P.
Argitaratua 2009

Obatoclax interacts synergistically with the irreversible proteasome inhibitor carfilzomib in GC- and ABC- DLBCL cells in vitro and in vivo

nork Dasmahapatra, Girija, Lembersky, Dmitry, Son, Minkyeong P., Patel, Hiral, Peterson, Derick, Attkisson, Elisa, Fisher, Richard I., Friedberg, Jonathan W., Dent, Paul, Grant, Steven
Argitaratua 2012

Retraction: Obatoclax Interacts Synergistically with the Irreversible Proteasome Inhibitor Carfilzomib in GC- and ABC-DLBCL Cells In Vitro and In Vivo

nork Dasmahapatra, Girija, Lembersky, Dmitry, Son, Minkyeong P., Patel, Hiral, Peterson, Derick, Attkisson, Elisa, Fisher, Richard I., Friedberg, Jonathan W., Dent, Paul, Grant, Steven
Argitaratua izan da Mol Cancer Ther (2019)

A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell...

nork Stopeck, Alison T., Unger, Joseph M., Rimsza, Lisa M., LeBlanc, Michael, Farnsworth, Brent, Iannone, Maria, Glenn, Martha J., Fisher, Richard I., Miller, Thomas P.
Argitaratua 2012

Optimal Management of Adverse Events From Copanlisib in the Treatment of Patients With Non-Hodgkin Lymphomas

nork Cheson, Bruce D., O’Brien, Susan, Ewer, Michael S., Goncalves, Marcus D., Farooki, Azeez, Lenz, Georg, Yu, Anthony, Fisher, Richard I., Zinzani, Pierre L., Dreyling, Martin
Argitaratua izan da Clin Lymphoma Myeloma Leuk (2018)

Prospective Study of Sequential Reduction in Immunosuppression, Interferon Alpha-2B, and Chemotherapy for Posttransplantation Lymphoproliferative Disorder

nork Swinnen, Lode J., LeBlanc, Michael, Grogan, Thomas M., Gordon, Leo I., Stiff, Patrick J., Miller, Alan M., Kasamon, Yvette, Miller, Thomas P., Fisher, Richard I.
Argitaratua 2008

Rituximab immunotherapy results in the induction of a lymphoma idiotype-specific T-cell response in patients with follicular lymphoma: support for a “vaccinal effect” of rituximab...

nork Hilchey, Shannon P., Hyrien, Ollivier, Mosmann, Tim R., Livingstone, Alexandra M., Friedberg, Jonathan W., Young, Faith, Fisher, Richard I., Kelleher, Raymond J., Bankert, Richard B., Bernstein, Steven H.
Argitaratua 2009